Clicky

Thursday, October 29, 2026

Companies

Public company updates

Great Southern Bancorp reports Q3 earnings decline

Great Southern Bancorp, Inc. reports a decline in Q3 earnings per share, impacted by non-cash accounting adjustments, amid challenges in the banking sector.

Brookfield Real Estate Income Trust Reports Unregistered Sales

Brookfield Real Estate Income Trust Inc. announces unregistered sales of equity securities, impacting its capital management strategy and the real estate investment trust sector.

Quality Industrial Corp. Restructures Purchase Obligations

Quality Industrial Corp. restructures its purchase obligations with Al Shola Gas, signaling a strategic shift in the industrial machinery sector.

Lattice Semiconductor adds two new directors to board

Lattice Semiconductor Corp expands its board by appointing two new directors, enhancing governance and strategic oversight in the semiconductor industry.

Fractyl Health announces workforce reduction, leadership change

Fractyl Health, Inc. announces a 45% workforce reduction and the retirement of its President, Jay Caplan, as part of a strategic shift.

Valion Bio names Dean Zikria as interim CEO, outlines plans

Valion Bio, Inc. appoints Dean Zikria as interim CEO, focusing on clinical pipeline advancements and shareholder value in the pharmaceutical preparations industry.

CenterPoint Energy's Subsidiary Secures $260M Bond Deal

CenterPoint Energy's subsidiary SIGECO secures $260 million in bond financing to refinance debt and fund capital projects, impacting the electric services industry.

Apollo Debt Solutions BDC Reports Strong Q3 2026 Performance

Apollo Debt Solutions BDC announces a 9.06% annualized distribution rate for Q3 2026, highlighting resilience amid market challenges.

United Bankshares Reports Third Quarter Earnings Results

United Bankshares, Inc. announces third-quarter earnings, reflecting slight profit decline but strong net interest income and disciplined expense management.

MIRA Pharmaceuticals Reports Positive Results for MIRA-55

MIRA Pharmaceuticals announces promising results from a preclinical study of MIRA-55, a potential pain relief drug, aiming for an IND submission in 2027.

Greene County Bancorp reports record Q1 net income of $12.5M

Greene County Bancorp, Inc. announces record net income of $12.5 million for Q1 2026, marking a 41% increase year-over-year.

Tron Inc. issues press release on recent developments

Tron Inc. announces updates via press release, impacting finance services sector and competitors.

Equity Lifestyle Properties reports Q3 results, forecasts growth

Equity Lifestyle Properties, Inc. announces Q3 results and growth expectations for 2027, highlighting gains in occupied sites.

Suburban Propane announces Fiscal 2026 Q4 distribution

Suburban Propane Partners LP announces its Fiscal 2026 Fourth Quarter Distribution Declaration, signaling commitment to shareholder returns.

Blue Owl Real Estate Trust Reports $31 Million Share Sale

Blue Owl Real Estate Net Lease Trust sells $31 million in shares, signaling strong demand and a positive outlook in the real estate market.

Smith & Wesson Completes Acquisition of Savage in Merger

Smith & Wesson Brands, Inc. has completed its acquisition of Savage, a significant move to strengthen its market position in the ordnance and accessories industry.

Kearny Financial holds Annual Meeting; key votes reported

Kearny Financial Corp. reports results from its Annual Meeting, including director elections and auditor appointments, impacting shareholder engagement.

Plumas Bancorp reports record Q3 2026 earnings growth

Plumas Bancorp announces record earnings for Q3 2026, with significant increases in net income and earnings per share, reflecting strong performance in the industry.

Banzai International Enters Repurchase Agreement for Warrants

Banzai International, Inc. announces a Repurchase Agreement to buy back warrants from an institutional investor, enhancing its financial strategy.

Inmune Bio partners with Uniphar for Ebstrocel commercialization

Inmune Bio, Inc. partners with Uniphar to enhance global access to Ebstrocel™, a therapy for Recessive Dystrophic Epidermolysis Bullosa, marking a key step in commercialization.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →